Therapeutic areas
About 80 therapeutic antibodies have been approved in Japan and more than 100 have been approved around the world
The main therapeutic areas for therapeutic antibody treatment include cancer and rheumatoid arthritis.
More than 100 therapeutic antibodies have been approved in countries like Japan, Europe, and the United States, and about 80 therapeutic antibodies are used in Japan with the approval of the Ministry of Health, Labor and Welfare.
| Indications (examples) | |
| Cancer | CD20-positive B-cell non-Hodgkin lymphoma Acute myeloid leukemia Colon cancer Breast cancer |
| Allergy・immunity | Rheumatoid arthritis Crohn's disease Psoriasis Asthma Atopic dermatitis |
| Infections, etc. | Prevention of infections in newborns and infants Age-related macular degeneration FGF23-related hypophosphatemic rickets/osteomalacia |